Soligenix, Inc.
SNGX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000812796
No open-market purchases or sales by Soligenix, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $369.6K in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Soligenix, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 28 | 30 | +2 |
| Shares | 3.19M | 3.10M | −91.7K (−2.9%) |
| Value | $1.91M | $1.35M | −$563.0K (−29.4%) |
New holders (4)
Institutions that held Soligenix, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 54,874 | $24.0K | 0.00% |
| Fiduciary Trust Co | 40,815 | $18.0K | 0.00% |
| Ground Swell Capital, LLC | 25,300 | $11.0K | 0.03% |
| UBS Group AG | 14,657 | $6.00K | 0.00% |
Sold out (2)
Institutions that held Soligenix, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Millennium Management LLC | 14,588 | $9.00K |
| Hartford Financial Management Inc. | 1,000 | $1.00K |